Stroke Therapy Candidate 3K3A-APC Holds Promise for Dementia

Article by Marisa Wexler MS. Alzheimer’s News Today – January 24, 2022.

3K3A-APC, an investigational therapy for stroke about to enter Phase 3 clinical testing, may also help to protect the brain against Alzheimer’s disease and other forms of dementia. “Our recent and current data support development of 3K3A-APC for neurological conditions associated with cognitive dysfunction such as Alzheimer’s disease and injury to the brain’s white matter that results in vascular dementia,” […]

Click here to view original web page at alzheimersnewstoday.com